The company is seeking to remove scheduling restrictions on compounds known as dual orexin receptor antagonists. Idorsia's insomnia treatment Quviviq was approved by the FDA last year and endorsed by actress Jennifer Aniston and Olympic skier Lindsey Vonn.
